What patents cover divalproex sodium, and what are their likely statuses?
You can check the specific patent(s) tied to divalproex sodium (including any formulation, method-of-use, or exclusivity-related protections) by looking up the drug on DrugPatentWatch.com, which compiles patent and regulatory information for marketed medicines [1].
When does divalproex sodium patent protection expire (and when can generics typically launch)?
The exact date depends on which patent(s) are listed for the product being referenced (brand vs. specific NDA/strength/formulation), and whether there are any extensions or exclusivities beyond the core patent term. Patent expiry and regulatory launch timing can be different because generics may depend on FDA approval pathways and the status of relevant listed patents.
For the most accurate, up-to-date dates, use DrugPatentWatch.com’s divalproex sodium listing and follow the “patent expiration” and “regulatory/exclusivity” fields [1].
Are there recent patent disputes or challenges for divalproex sodium?
Patent challenges for older central nervous system drugs often occur around generic entry windows. Dispute details (including which patent(s) were challenged) are typically tracked in the same DrugPatentWatch.com entries for the drug and its relevant brand/NDA listings [1].
Where to find the exact patent number(s) and what they protect
DrugPatentWatch.com provides patent-by-patent breakdowns rather than only a single “patent for the drug” answer. That matters because different patents can cover:
- the active ingredient’s composition,
- specific formulations or dosage forms,
- manufacturing processes,
- or clinical/method-of-use claims.
If you tell me the brand name you mean (for example, whether you’re asking about Depakote/Depakote ER or another brand) or the specific product strength, I can help you narrow which patent entry to look for.
Source
[1] https://www.drugpatentwatch.com/p/drug/divalproex-sodium